TCL Archive Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million April 12, 1985
TCL Archive Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show November 28, 1986
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005